Structural basis for HIV-1 antagonism of host APOBEC3G via Cullin E3 ligase.
Fumiaki ItoAna L Alvarez-CabreraShiheng LiuHanjing YangAnna ShiriaevaZ Hong ZhouXiaojiang S ChenPublished in: Science advances (2023)
Human APOBEC3G (A3G) is a virus restriction factor that inhibits HIV-1 replication and triggers lethal hypermutation on viral reverse transcripts. HIV-1 viral infectivity factor (Vif) breaches this host A3G immunity by hijacking a cellular E3 ubiquitin ligase complex to target A3G for ubiquitination and degradation. The molecular mechanism of A3G targeting by Vif-E3 ligase is unknown, limiting the antiviral efforts targeting this host-pathogen interaction crucial for HIV-1 infection. Here, we report the cryo-electron microscopy structures of A3G bound to HIV-1 Vif in complex with T cell transcription cofactor CBF-β and multiple components of the Cullin-5 RING E3 ubiquitin ligase. The structures reveal unexpected RNA-mediated interactions of Vif with A3G primarily through A3G's noncatalytic domain, while A3G's catalytic domain is poised for ubiquitin transfer. These structures elucidate the molecular mechanism by which HIV-1 Vif hijacks the host ubiquitin ligase to specifically target A3G to establish infection and offer structural information for the rational development of antiretroviral therapeutics.
Keyphrases
- antiretroviral therapy
- hiv positive
- hiv infected
- human immunodeficiency virus
- hiv aids
- hiv testing
- hepatitis c virus
- men who have sex with men
- hiv infected patients
- high resolution
- electron microscopy
- south africa
- sars cov
- structural basis
- endothelial cells
- healthcare
- mass spectrometry
- genome wide
- single cell
- quality improvement
- candida albicans
- transcription factor